Correlation Between Clarity Pharmaceuticals and Apple

Can any of the company-specific risk be diversified away by investing in both Clarity Pharmaceuticals and Apple at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clarity Pharmaceuticals and Apple into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Clarity Pharmaceuticals and Apple Inc, you can compare the effects of market volatilities on Clarity Pharmaceuticals and Apple and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clarity Pharmaceuticals with a short position of Apple. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clarity Pharmaceuticals and Apple.

Diversification Opportunities for Clarity Pharmaceuticals and Apple

-0.58

Correlation Coefficient

Clarity Pharmaceuticals  Apple

Excellent diversification

The 3 months correlation between Clarity and Apple is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Clarity Pharmaceuticals and Apple Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apple Inc and Clarity Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clarity Pharmaceuticals are associated (or correlated) with Apple. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apple Inc has no effect on the direction of Clarity Pharmaceuticals i.e., Clarity Pharmaceuticals and Apple go up and down completely randomly.

Pair Corralation between Clarity Pharmaceuticals and Apple

Assuming the 90 days horizon Clarity Pharmaceuticals is expected to generate 5.42 times more return on investment than Apple. However, Clarity Pharmaceuticals is 5.42 times more volatile than Apple Inc. It trades about -0.05 of its potential returns per unit of risk. Apple Inc is currently generating about -0.49 per unit of risk. If you would invest  294.00  in Clarity Pharmaceuticals on October 25, 2024 and sell it today you would lose (37.00) from holding Clarity Pharmaceuticals or give up 12.59% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Clarity Pharmaceuticals  vs.  Apple Inc

Clarity Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Clarity Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Apple Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apple Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Apple is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Clarity Pharmaceuticals and Apple

The main advantage of trading using opposite Clarity Pharmaceuticals and Apple positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clarity Pharmaceuticals position performs unexpectedly, Apple can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apple will offset losses from the drop in Apple's long position.

The idea behind Clarity Pharmaceuticals and Apple Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.